Sixteen years ago, when I was a medical student interested in malaria, my professor of
medicine asked me what the chances were of developing a malaria vaccine. So far, a …

To the Editor: In the article by the RTS, S Clinical Trials Partnership (Nov. 17 issue) 1 on the
phase 3 trial of RTS, S (ClinicalTrials. gov number, NCT00866619), an analysis of the …

A vaccine against malaria has gained regulatory approval for the first time. Mosquirix,
developed by GlaxoSmithKline, has been approved by the European Medicines Agency …

WHO’s rollout of malaria vaccine in Africa: can safety questions be answered after only 24
months? Page 1 WHO’s rollout of malaria vaccine in Africa: can safety questions be …

Calls are being made both at national 1 and international 2 level, to vaccinate whole
populations against hepatitis B. Such exhortations are based on the fact that for the past 15 …

Vaccines are, indisputably, one of the greatest public health interventions, with a substantial
positive impact on child survival. The remarkable declines in child mortality observed during …

The Global Alliance for Vaccines and Immunisation (GAVI), now known as the GAVI
Alliance, was created in 2000 to increase the availability and use of immunisation in poor …

The RTS, S malaria vaccine was recently recommended for use among children at risk in
malaria endemic regions. Although significant efforts have been made to minimise malaria …

Two recent studies by Philip Bejon1 and Salim Abdulla, 2 and their respective colleagues,
represent an important step towards the development of a malaria vaccine that shows great …

Malaria vaccine cautiously recommended for use in Africa. - Abstract - Europe PMC Sign in |
Create an account https://orcid.org Europe PMC Menu About Tools Developers Help Contact …